China's biotech surge highlights work-life tension for industry leaders

China's biotechnology sector is accelerating, prompting discussions about the demanding work culture among its leaders.

Shefali Agarwal, the US‑based chief executive of Sironax, said she works long hours because she is passionate about delivering effective medicines to patients.

Observers note that the rapid pace of development in Chinese biotech is putting pressure on staff, raising concerns about sustainability and talent retention in the industry.